Form 8-K - Current report:
SEC Accession No. 0001213900-24-035050
Filing Date
2024-04-23
Accepted
2024-04-22 19:02:20
Documents
13
Period of Report
2024-04-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204363-8k_lucy.htm   iXBRL 8-K 21976
  Complete submission text file 0001213900-24-035050.txt   194776

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lsdi-20240417.xsd EX-101.SCH 3033
3 XBRL LABEL FILE lsdi-20240417_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lsdi-20240417_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0204363-8k_lucy_htm.xml XML 3686
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 24862362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)